Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/11/25 20:50 | 8/21/25 | GNLX | Health | Drug | Pharmaceutical Preparations | Yu Yong | CA | O | SVP,Clin | 1 | S.m | -16 | 3.82 | 0 | -4 | 146 | D | |||||||||||||||
12/11/25 20:50 | 8/21/25 | GNLX | Health | Drug | Pharmaceutical Preparations | Zindrick Thomas | CA | O | P,CEO | 1 | S.m | -66 | 3.86 | 0 | -17 | 538 | D | |||||||||||||||
12/11/25 20:49 | 8/21/25 | GNLX | Health | Drug | Pharmaceutical Preparations | Cappello Joseph | CA | O | Chief Te | 1 | S.m | -14 | 3.88 | 0 | -4 | 156 | D | |||||||||||||||
12/9/25 20:00 | 8/21/25 | GNLX | Health | Drug | Pharmaceutical Preparations | Smalling Ralph | CA | O | Head of | 1 | S.m | -9 | 3.75 | 0 | -2 | 69 | D | |||||||||||||||
12/2/25 19:00 | 12/1/25 | GNLX | Health | Drug | Pharmaceutical Preparations | Thomas John | CA | D | 1 | S | -50 | 5.00 | 0 | -10 | 493 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |